Interleukin-15 in HIV infection: immunological and virological interactions in antiretroviral-naive and -treated patients.
about
The role of interleukin-15 in inflammation and immune responses to infection: implications for its therapeutic useDifferential effects of interleukin-7 and interleukin-15 on NK cell anti-human immunodeficiency virus activity.Influence of cytokines on HIV-specific antibody-dependent cellular cytotoxicity activation profile of natural killer cells.Interleukin-15 (IL-15) Strongly Correlates with Increasing HIV-1 Viremia and Markers of Inflammation.Innate immune defenses in HIV-1 infection: prospects for a novel immune therapy.Neonatal natural killer cell function: relevance to antiviral immune defenseRole of interleukin-15 in umbilical cord blood transplantation.Recent advances targeting innate immunity-mediated therapies against HIV-1 infection.Immunotherapeutic applications of IL-15.Interleukin-15 production by monocyte-derived dendritic cells and T cell proliferation in HIV-infected patients with discordant response to highly active antiretroviral therapy.Clinical manufacturing of recombinant human interleukin 15. I. Production cell line development and protein expression in E. coli with stop codon optimization.CD161 Expression on Mucosa-Associated Invariant T Cells is Reduced in HIV-Infected Subjects Undergoing Antiretroviral Therapy Who Do Not Recover CD4+ T Cells.NK cells, displaying early activation, cytotoxicity and adhesion molecules, are associated with mild dengue disease.Distinctive in vitro effects of T-cell growth cytokines on cytomegalovirus-stimulated T-cell responses of HIV-infected HAART recipients.Killing of Kaposi's sarcoma-associated herpesvirus-infected fibroblasts during latent infection by activated natural killer cellsInterleukin-15 increases effector memory CD8+ t cells and NK Cells in simian immunodeficiency virus-infected macaques.IL-15 treatment during acute simian immunodeficiency virus (SIV) infection increases viral set point and accelerates disease progression despite the induction of stronger SIV-specific CD8+ T cell responses.SIV-specific T lymphocyte responses in PBMC and lymphoid tissues of SIV-infected pigtailed macaques during suppressive combination antiretroviral therapy.An IL-15 dependent CD8 T cell response to selected HIV epitopes is related to viral control in early-treated HIV-infected subjects.
P2860
Q24599103-FAB7A2B8-3979-4AF6-AB00-C6C4C7BCF251Q34150316-F78CD78B-20F3-4595-921C-E7B9E5AE4505Q34305570-A64A693A-263F-41DF-9F42-F768AA0686E7Q36202607-B483CD39-32D4-4EAB-A89E-2B7D86998FD6Q36670882-D0B2FA87-0E82-415C-86EB-E157E42E3824Q37162875-BF7CC2E9-8DF1-46BD-BD2C-7AFE2F50225DQ37344241-9E15A001-841E-4742-9EBF-FD21F69047E0Q38035344-8F6B6EAE-DEEF-43C2-81B4-20A26F78F5E5Q38050510-DF35AC52-E7EC-4257-BAA7-7F21AA5D2AF7Q38959284-4D41B2EE-A4EF-42AF-AC3E-D0B378F6477CQ39429309-C16B7F45-6D6F-48AE-91BA-8990E96E31B4Q40059465-661B0A35-9589-4CD0-B32A-466D843A2DBCQ40488687-A46A3A10-5269-4FBE-A45D-87F1E9FE1001Q41339628-F3E7974E-0B19-431A-8318-B765A1856093Q41594489-3CE8B634-8C82-4127-B875-024AECC5EED6Q42027307-F953AF3D-EBE4-4AB3-AE79-8443A37CDAF0Q42453465-3C0FE7EA-9DDC-4ABE-91AE-B3ABBC678860Q46462494-DDA543B3-0512-4DF4-A6CF-95E48D7EB5ABQ51971392-19A69242-CEF6-4A78-B4C7-8536B599E25F
P2860
Interleukin-15 in HIV infection: immunological and virological interactions in antiretroviral-naive and -treated patients.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Interleukin-15 in HIV infectio ...... l-naive and -treated patients.
@en
type
label
Interleukin-15 in HIV infectio ...... l-naive and -treated patients.
@en
prefLabel
Interleukin-15 in HIV infectio ...... l-naive and -treated patients.
@en
P2093
P50
P1433
P1476
Interleukin-15 in HIV infectio ...... al-naive and -treated patients
@en
P2093
Fabio Mengoni
Gabriele Forcina
Miriam Lichtner
Vincenzo Vullo
P304
P356
10.1097/00002030-200201250-00006
P407
P577
2002-01-01T00:00:00Z